Second-Line Agents for the Treatment of Type 2 Diabetes and Prevention of CKD.
Divisions of Nephrology and.
Margaret K
MK
Yu
Endocrinology, Stanford University School of Medicine, Stanford, California.
Sun H
SH
Kim
D003924:Diabetes Mellitus, Type 2; D003928:Diabetic Nephropathies; D006801:Humans; D007004:Hypoglycemic Agents; D051436:Renal Insufficiency, Chronic
D007004:Hypoglycemic Agents
Chronic; Diabetes Mellitus; Kidney Failure; Renal Insufficiency; Type 2; diabetic nephropathy